RECURSION PHARMACEUTICALS, INC. (RXRX) › Capital ExpendituresRECURSION PHARMACEUTICALS, INC. (RXRX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2019: $3.91M2020: $5.83M2021: $39.80M2022: $37.06M2023: $11.96M2024: $13.70M2025: $6.47M$6.47M2019Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$6.47M-52.8%2024$13.70M+14.6%2023$11.96M-67.7%2022$37.06M-6.9%2021$39.80M+582.5%2020$5.83M+49.1%2019$3.91M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share